PHAR MEXC RealStocks
Own real PHAR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 08:01:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Pharming Group N.V. ADS, each representing 10 (PHAR) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $12.43, with a market capitalization of $853.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.11 to $21.34. This page covers its latest market performance, valuation, price trends and company information.
$853.58M | |
$12.32 | |
$12.48 | |
$11.51 | |
$12.06 | |
5.91K | |
21.55K | |
-- | |
$21.34 | |
$9.11 | |
-- | |
2026-09-30 |
Pharming Group N.V. ADS, each representing 10 (PHAR) last closed at $12.43 as of 2026-11-19 00:31:00, up 0.85% ($0.11) from the previous close of $12.06.
During the latest regular trading session, PHAR traded between $11.51 and $12.48, with a volume of 5.91K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Pharming Group N.V. ADS, each representing 10 (PHAR) moved from $13.22 to $12.43, representing a decline of 6.01% ($0.79).
The stock traded between $11.51 and $13.40 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 8.94 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27.1%
PHAR is currently trading at $12.43, placing it 27.1% of the way from its 52-week low of $9.11 to its 52-week high of $21.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
| Employees | 409 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Pharming Group N.V. ADS, each representing 10 (PHAR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PHAR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between PHAR shares and USD.
PHAR Shares to USD
1.00 PHAR shares = 12.425 USD
Calculations are estimates based on the latest available price and are for reference only.